Valneva to present on chikungunya at several leading scientific conferences

Saint-herblain (france), october 11, 2023 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, announces today it will present on the mosquito-borne chikungunya disease at several leading scientific conferences during the fourth quarter of 2023.
VALN Ratings Summary
VALN Quant Ranking